BCSF vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health scores paint a concerning picture, with a Piotroski F-Score of just 2/9 indicating weak financial health, and the absence of an Altman Z-Score prevents a full solvency assessment but raises transparency concerns. Despite a high dividend yield of 12.25%, the payout ratio of 116.67% is unsustainable, and declining earnings (YoY EPS down 15.1%) undermine profitability. Valuation appears cheap on P/E (9.47) and P/B (0.78) but this reflects fundamental deterioration rather than value opportunity. Technical trend is deeply bearish (0/100), and insider sentiment is weak at 40/100, reinforcing negative momentum.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BCSF vs JPM: Head-to-Head Comparison
This page compares Bain Capital Specialty Finance, Inc. (BCSF) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.